Advertisement

Topics

Boehringer Ingelheim expands collaboration with Vanderbilt University to tackle some of the most difficult-to-treat cancers

08:00 EST 2 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
New collaboration with Vanderbilt University investigates novel approaches to block KRAS: the Kerstin Rat Sarcoma viral oncogene that is an important driver in lung, colorectal and pancreatic cancer B...

Other Sources for this Article

Boehringer Ingelheim
Dr. Reinhard Malin – Ex-US Media
Corporate Communications – Innovation Unit
Phone: 49 (6132) 77-90815
reinhard.malin@boehringer-ingelheim.com
or
Linda Ruckel – US media
Associate Director, Media and Corporate Reputation
Phone: 203-791-6672
linda.ruckel@boehringer-ingelheim.com

NEXT ARTICLE

More From BioPortfolio on "Boehringer Ingelheim expands collaboration with Vanderbilt University to tackle some of the most difficult-to-treat cancers"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...